tipapkinogene sovacivec,avelumab
transgene,Merck,Pfizer
['tg4001', 'transgene']
transgene presents immunological data demonstrating that tg4001, a novel therapeutic cancer vaccine, can induce t-cell responses against hpv16 antigens in the ongoing phase ii trial at asco 2023 #businesswire 
Stock Market News and Press Releases. #StockMarket & #Crypto